ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
6.00
-0.37 (-5.81%)
At close: Aug 1, 2025, 4:00 PM
5.95
-0.05 (-0.83%)
After-hours: Aug 1, 2025, 6:48 PM EDT
ImmuCell Employees
As of December 31, 2024, ImmuCell had 75 total employees, including 69 full-time and 6 part-time employees. The number of employees decreased by 4 or -5.06% compared to the previous year.
Employees
75
Change (1Y)
-4
Growth (1Y)
-5.06%
Revenue / Employee
$364,037
Profits / Employee
-$3,624
Market Cap
54.22M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 75 | -4 | -5.06% |
| Dec 31, 2023 | 79 | 5 | 6.76% |
| Dec 31, 2022 | 74 | 7 | 10.45% |
| Dec 31, 2021 | 67 | 6 | 9.84% |
| Dec 31, 2020 | 61 | 7 | 12.96% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 94,300 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
ICCC News
- 24 days ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q2 of 2025 - GlobeNewsWire
- 5 weeks ago - ImmuCell Embarks on CEO Succession Planning Process - GlobeNewsWire
- 2 months ago - ImmuCell to Hold Virtual-Only Annual Meeting of Stockholders - GlobeNewsWire
- 2 months ago - ImmuCell Corporation (ICCC) Q1 2025 Earnings Call Transcript - Seeking Alpha
- 2 months ago - ImmuCell Announces Unaudited Financial Results for the Quarter Ended March 31, 2025 - GlobeNewsWire
- 2 months ago - ImmuCell to Announce Unaudited Financial Results for the Quarter Ended March 31, 2025 - GlobeNewsWire
- 4 months ago - ImmuCell Announces Preliminary, Unaudited Sales Results for Q1 of 2025 - GlobeNewsWire
- 4 months ago - ImmuCell Announces Initiation of Investigational Product Use of Re-Tain® - GlobeNewsWire